SCICONX Journal of Immunity and Infectious Diseases

Welcome to the SCICONX Journal of Immunity and Infectious Diseases (JIID), an international platform dedicated to advancing knowledge at the intersection of immunology, infectious diseases, and global health. As part of SCICONX Publishing, JIID provides a trusted space where groundbreaking research, clinical insights, and innovative therapies are brought together to improve human health worldwide.

✦ Our Vision

The journal strives to bridge the gap between laboratory discoveries and real-world applications, enabling scientists, clinicians, and policymakers to better understand immune mechanisms, combat emerging infections, and strengthen preparedness against global health challenges.

✦ Scope of the Journal

JIID welcomes high-quality contributions across a wide spectrum of topics, including but not limited to:

• Immune system function, regulation, and dysregulation
• Host–pathogen interactions and molecular mechanisms of infection
• Vaccine research, immunotherapies, and novel prophylactic strategies
• Antimicrobial resistance and evolving infectious threats
• Epidemiology and outbreak investigation
• Diagnostic innovations and clinical management of infectious diseases
• Translational research linking immunity to disease prevention and treatment
• Public health strategies, global policy, and preparedness for pandemics

✦ What Makes JIID Unique

Unlike many journals that narrowly define their scope, JIID emphasizes a multidisciplinary approach - bringing together contributions from basic science, clinical practice, and global health perspectives. The journal encourages cross-cutting research that connects immunology, microbiology, virology, epidemiology, and biotechnology to accelerate solutions for pressing health concerns.

✦ Why Publish with JIID?

• Global Reach – Articles are disseminated to an international readership of researchers, clinicians, and policymakers.
• Rigorous Peer Review – Each submission undergoes a thorough evaluation by experts to ensure quality, novelty, and relevance.
• Rapid & Transparent Process – JIID prioritizes timely reviews and clear communication with authors.
• Open Access Commitment – Research is freely accessible, amplifying visibility and impact across scientific and medical communities.
• Platform for Innovation – Special issues, thematic collections, and invited reviews spotlight emerging areas and urgent challenges.

✦ Fast Editorial Execution and Review Process (FEE-Review Process)

Authors who are willing to publish their articles under this mode can make a pre-payment of € 99 towards express peer-review and editorial decision. First editorial decision in 3 days and final decision with review comments in 5 days from the date of submission. Galley proof generation will be done in next 2 days from acceptance or maximum 5 days (For manuscripts notified for revision by external reviewer). 

Manuscripts accepted for publication will be charged regular APC.

Authors retain the copyright of their publication and the final version of the article will be published in both HTML and PDF formats as well as XML formats for transmitting to indexing databases. The editorial team of the Journal will ensure adherence to scientific publication guidelines.

✦ Our Community

JIID is more than just a journal - it is a collaborative hub where scientists, healthcare professionals, and thought leaders share knowledge to foster innovation and advance patient care. By publishing with JIID, authors contribute to a collective effort to strengthen immunity, fight infections, and safeguard global health.

Whether you are a researcher exploring immune pathways, a clinician addressing infectious disease challenges, or a policymaker shaping global health responses, JIID invites you to be part of this journey.